AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11736729 — intervention group
Group type: EXPERIMENTAL
Intervention: ranitidine bismuth citrate, furazolidone, amoxicillin
Number of subjects: 120
Study 11736729 — intervention group
Group type: EXPERIMENTAL
Intervention: ranitidine bismuth citrate, furazolidone, tetracycline
Number of subjects: 120
Study 9246988 — intervention group
Group type: EXPERIMENTAL
Intervention: External fixation a.m. Hoffmann
Number of subjects: 60
Study 9246988 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous Kirschner wire pinning combined with immobilization in a plaster cast
Number of subjects: 60
Study 8000793 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous measurements of free, oligomer‐bound and protein‐bound sialic acids in blood serum, saliva, and tissue homogenates
Number of subjects: 0
Study 3712426 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior modification clinics followed by an intensive media campaign
Number of subjects: 0
Study 3712426 — intervention group
Group type: COMPARATOR
Intervention: Behavior modification clinics alone
Number of subjects: 0
Study 3712426 — intervention group
Group type: COMPARATOR
Intervention: Packet of smoking cessation material in the mail
Number of subjects: 0
Study 30540552 — intervention group
Group type: EXPERIMENTAL
Intervention: Coinfection of 11 generalist viruses
Number of subjects: 47
Study 30540552 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized regression models
Number of subjects: 47
Study 30540552 — intervention group
Group type: EXPERIMENTAL
Intervention: Network analyses of coinfection
Number of subjects: 47
Study 30540552 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecological interactions
Number of subjects: 47
Study 29523206 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based humanistic counselling (SBHC) delivered in up to 10 weekly sessions by a qualified counsellor.
Number of subjects: 306
Study 29523206 — intervention group
Group type: COMPARATOR
Intervention: Pastoral Care as Usual (PCAU)
Number of subjects: 306
Study 29523206 — intervention group
Group type: EXPERIMENTAL
Intervention: SBHC
Number of subjects: 306
Study 26108438 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training for 16 weeks
Number of subjects: 43
Study 26108438 — intervention group
Group type: COMPARATOR
Intervention: Control group (diabetes without neuropathy and healthy controls)
Number of subjects: 43
Study 25493153 — intervention group
Group type: EXPERIMENTAL
Intervention: Online ACLS simulator access (n=29)
Number of subjects: 65
Study 25493153 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=36)
Number of subjects: 65
Study 23672102 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval training program (n=140) for 8 weeks, 45-60 minutes at 60-79% HR reserve
Number of subjects: 245
Study 23672102 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=105) remained sedentary
Number of subjects: 245
Study 20173082 — intervention group
Group type: EXPERIMENTAL
Intervention: Telcagepant single oral doses (up to 1200 mg)
Number of subjects: 0
Study 20173082 — intervention group
Group type: EXPERIMENTAL
Intervention: Telcagepant multiple oral doses (400 mg twice daily)
Number of subjects: 0
Study 18005835 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical headgear combined with full fixed appliances
Number of subjects: 60
Study 18005835 — intervention group
Group type: COMPARATOR
Intervention: Pendulum appliance followed by full fixed appliances
Number of subjects: 60
Study 16027585 — intervention group
Group type: EXPERIMENTAL
Intervention: Firearm safety training using scripted discussion, psychomotor exercise, and role-playing exercise
Number of subjects: 57
Study 16027585 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 57
Study 12665049 — intervention group
Group type: EXPERIMENTAL
Intervention: Two 80‐mg tablets twice daily
Number of subjects: 100
Study 12665049 — intervention group
Group type: EXPERIMENTAL
Intervention: Two 80‐mg tablets three times daily
Number of subjects: 100
Study 12665049 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 100
Study 9808910 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmenopausal women
Number of subjects: 82
Study 9808910 — intervention group
Group type: COMPARATOR
Intervention: Pre-menopausal women (control)
Number of subjects: 82
Study 7631952 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine with fentanyl (group B-F)
Number of subjects: 36
Study 7631952 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine with sufentanil (group B-S)
Number of subjects: 36
Study 7631952 — intervention group
Group type: COMPARATOR
Intervention: Epidural bupivacaine alone (group B)
Number of subjects: 36
Study 2654214 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily (nonoccluded) superpotent topical steroids for 2 weeks
Number of subjects: 118
Study 962352 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical glucocorticosteroids
Number of subjects: 10
Study 962352 — intervention group
Group type: COMPARATOR
Intervention: Matched control group (no steroid treatment)
Number of subjects: 10
Study 962352 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical glucocorticosteroids (retesting after one month)
Number of subjects: 10
Study 30104408 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparative risk messages (CR messages)
Number of subjects: 1400
Study 30104408 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparative risk messages with more negative antismoking elements (CR- messages)
Number of subjects: 1400
Study 30104408 — intervention group
Group type: COMPARATOR
Intervention: Control message
Number of subjects: 1400
Study 28498275 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (2-week duration)
Number of subjects: 105
Study 28498275 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo (2-week duration)
Number of subjects: 105
Study 25445851 — intervention group
Group type: EXPERIMENTAL
Intervention: Early voice therapy (within 4 weeks from injury)
Number of subjects: 171
Study 25445851 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate voice therapy (from 4 to 8 weeks after injury)
Number of subjects: 171
Study 25445851 — intervention group
Group type: COMPARATOR
Intervention: Delayed voice therapy (at least 8 weeks after injury)
Number of subjects: 171
Study 23368699 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-based intervention using email to augment in-person seminars
Number of subjects: 71
Study 23368699 — intervention group
Group type: COMPARATOR
Intervention: Control group (no case-based intervention)
Number of subjects: 71
Study 21632552 — intervention group
Group type: EXPERIMENTAL
Intervention: sTNF-R1 (quartile 4 vs. quartile 1)
Number of subjects: 297
Study 21632552 — intervention group
Group type: EXPERIMENTAL
Intervention: sCD27
Number of subjects: 297
Study 21632552 — intervention group
Group type: EXPERIMENTAL
Intervention: sTNF-R1 (for cases diagnosed longer than 6 years post-collection)
Number of subjects: 297
Study 21632552 — intervention group
Group type: EXPERIMENTAL
Intervention: sCD27 (for cases diagnosed longer than 6 years post-collection)
Number of subjects: 297
Study 21632552 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-10
Number of subjects: 297
Study 21632552 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF-α
Number of subjects: 297
Study 21632552 — intervention group
Group type: EXPERIMENTAL
Intervention: sTNF-R2
Number of subjects: 297
Study 19368922 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid-iron
Number of subjects: 3986
Study 19368922 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrients
Number of subjects: 3986
Study 19368922 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid-iron, folic acid-iron-zinc, and multiple micronutrients
Number of subjects: 3986
Study 17299383 — intervention group
Group type: EXPERIMENTAL
Intervention: Olibra yoghurt
Number of subjects: 50
Study 17299383 — intervention group
Group type: COMPARATOR
Intervention: Placebo yoghurt
Number of subjects: 50
Study 15497550 — intervention group
Group type: EXPERIMENTAL
Intervention: High-resolution kinetic mapping method
Number of subjects: 24
Study 15497550 — intervention group
Group type: COMPARATOR
Intervention: Static mapping
Number of subjects: 24
Study 11323139 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful heat (540 mJ punctate laser stimuli, 5 mm diameter)
Number of subjects: 12
Study 11323139 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-painful touch (16 mN von Frey probe, 1.1 mm diameter)
Number of subjects: 12
Study 11323139 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanically-induced pain (256 mN punctate probe, 200 microm diameter)
Number of subjects: 12
Study 11323139 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential spatial discrimination for touch
Number of subjects: 12
Study 11323139 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger tip localization
Number of subjects: 12
Study 9783189 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term intravesical instillation of pirarubicin (THP) for daily for 7 consecutive days from the day of TUR-BT and subsequently once a week for 10 weeks (17 times in total)
Number of subjects: 69
Study 9783189 — intervention group
Group type: COMPARATOR
Intervention: Short-term intravesical instillation of pirarubicin (THP) once every two weeks for 6 months (12 times) starting 2 weeks after TUR and subsequently once a month until one year had passed after surgery (6 times, 18 times in total)
Number of subjects: 69
Study 7870558 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual distractors (computer-generated dynamic graphic images) during skilled proofreading task
Number of subjects: 32
Study 7870558 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual distractors (computer-generated dynamic graphic images) during unskilled proofreading task
Number of subjects: 32
Study 7870558 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual distractors (computer-generated dynamic graphic images) during listening comprehension task
Number of subjects: 32
Study 3127600 — intervention group
Group type: EXPERIMENTAL
Intervention: Keyhole-limpet hemocyanin (1 mg intracutaneously for immunization, followed by 10 mg monthly bladder instillations)
Number of subjects: 44
Study 3127600 — intervention group
Group type: EXPERIMENTAL
Intervention: Keyhole-limpet hemocyanin (10 mg monthly bladder instillations)
Number of subjects: 44
Study 3127600 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C (20 mg monthly)
Number of subjects: 44
Study 30651321 — intervention group
Group type: EXPERIMENTAL
Intervention: TTP399 (800 mg/day)
Number of subjects: 0
Study 30651321 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28282300 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir Alafenamide (TAF)
Number of subjects: 1733
Study 28282300 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir Disoproxil Fumarate (TDF)
Number of subjects: 1733
Study 25848134 — intervention group
Group type: EXPERIMENTAL
Intervention: rhPDGF‐BB/β‐TCP‐collagen
Number of subjects: 75
Study 25848134 — intervention group
Group type: COMPARATOR
Intervention: autograft
Number of subjects: 75
Study 23412171 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic microfracture with PRP (24 patients)
Number of subjects: 49
Study 23412171 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic microfracture only (25 patients)
Number of subjects: 49
Study 21134693 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenograstim
Number of subjects: 0
Study 21134693 — intervention group
Group type: COMPARATOR
Intervention: Filgrastim
Number of subjects: 0
Study 19225876 — intervention group
Group type: EXPERIMENTAL
Intervention: E(2) pre‐treatment group (n=109)
Number of subjects: 220
Study 19225876 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=111)
Number of subjects: 220
Study 17129185 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with striatal lesions
Number of subjects: 0
Study 17129185 — intervention group
Group type: COMPARATOR
Intervention: Patients with frontal lobe lesions
Number of subjects: 0
Study 17129185 — intervention group
Group type: COMPARATOR
Intervention: Baseline nonswitch trials
Number of subjects: 0
Study 15192923 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculated insulin dose (CALC)
Number of subjects: 60
Study 15192923 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin dose (C)
Number of subjects: 60
Study 11275919 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting antianginal medications (long-acting diltiazem +/− nitroglycerin patches +/− atenolol)
Number of subjects: 100
Study 11275919 — intervention group
Group type: COMPARATOR
Intervention: Optimal adjustment of usual antianginal medications
Number of subjects: 100
Study 9294499 — intervention group
Group type: EXPERIMENTAL
Intervention: Capnography
Number of subjects: 55
Study 9294499 — intervention group
Group type: COMPARATOR
Intervention: Auscultation of breath sounds
Number of subjects: 55
Study 8438711 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician-delivered smoking interventions
Number of subjects: 1261
Study 3525343 — intervention group
Group type: EXPERIMENTAL
Intervention: Melphalan
Number of subjects: 185
Study 3525343 — intervention group
Group type: COMPARATOR
Intervention: Melphalan plus C. parvum
Number of subjects: 185
Study 31152310 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryopreserved umbilical cord (UC) allograft
Number of subjects: 200
Study 31152310 — intervention group
Group type: COMPARATOR
Intervention: Control (no UC)
Number of subjects: 200
Study 30144421 — intervention group
Group type: EXPERIMENTAL
Intervention: Thin bronchoscope and radial endobronchial ultrasound (TB-EBUS)
Number of subjects: 197
Study 30144421 — intervention group
Group type: COMPARATOR
Intervention: Standard bronchoscopy and fluoroscopy (SB-F)
Number of subjects: 197
Study 30144421 — intervention group
Group type: COMPARATOR
Intervention: Standard bronchoscopy and fluoroscopy (SB-F) with crossover to TB-EBUS
Number of subjects: 197
Study 27166077 — intervention group
Group type: COMPARATOR
Intervention: Psyllium 3.4 g
Number of subjects: 0
Study 27166077 — intervention group
Group type: COMPARATOR
Intervention: Psyllium 6.8 g
Number of subjects: 0
Study 27166077 — intervention group
Group type: COMPARATOR
Intervention: Psyllium 10.2 g
Number of subjects: 0
Study 27166077 — intervention group
Group type: COMPARATOR
Intervention: Psyllium 6.8 g (Study 2)
Number of subjects: 0
Study 27166077 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 0
Study 23895084 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma‐focused cognitive behavioral therapy (TF‐CBT)
Number of subjects: 156
Study 23895084 — intervention group
Group type: COMPARATOR
Intervention: Therapy as usual (TAU)
Number of subjects: 156
Study 22745116 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior catheter tip placement
Number of subjects: 32
Study 22745116 — intervention group
Group type: COMPARATOR
Intervention: Posterior catheter tip placement
Number of subjects: 32
Study 20557327 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA) administered subcutaneously every 2 weeks, titrated to maintain a target Hb level of 14.0±1.0 g/dL
Number of subjects: 475
Study 20557327 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA)
Number of subjects: 475
Study 20557327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 475
Study 18657736 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical reinsertion of the medial patellofemoral ligament (MPFL) to the adductor tubercle
Number of subjects: 80
Study 18657736 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (use of a brace with 0 degrees to 20 degrees motion for the first 2 weeks after dislocation)
Number of subjects: 80
Study 15877291 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2 g/min of glucose (GLU)
Number of subjects: 8
Study 15877291 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2 g/min of sucrose (SUC)
Number of subjects: 8
Study 15877291 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 g/min of glucose + 0.6 g/min of sucrose (M-GLU+SUC)
Number of subjects: 8
Study 15877291 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2 g/min of glucose + 1.2 g/min of sucrose (H-GLU+SUC)
Number of subjects: 8
Study 15877291 — intervention group
Group type: COMPARATOR
Intervention: Water (WAT)
Number of subjects: 8
Study 12689354 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocalists
Number of subjects: 22
Study 12689354 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 22
Study 12552030 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 500 mg/d
Number of subjects: 252
Study 12552030 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 200 mg/d
Number of subjects: 252
Study 12552030 — intervention group
Group type: COMPARATOR
Intervention: Topiramate 50 mg/d
Number of subjects: 252
Study 9802630 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzathine penicillin G diluted with lidocaine hydrochloride 1%
Number of subjects: 18
Study 9802630 — intervention group
Group type: COMPARATOR
Intervention: Benzathine penicillin G diluted with sterile water
Number of subjects: 18
Study 7706451 — intervention group
Group type: EXPERIMENTAL
Intervention: Table wine (ethanol content 71 g)
Number of subjects: 14
Study 7706451 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 14
Study 2568808 — intervention group
Group type: EXPERIMENTAL
Intervention: Iotrolan
Number of subjects: 60
Study 2568808 — intervention group
Group type: COMPARATOR
Intervention: Iopromide
Number of subjects: 60
Study 2568808 — intervention group
Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 60
Study 1066333 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol (X)
Number of subjects: 102
Study 1066333 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose (F)
Number of subjects: 102
Study 1066333 — intervention group
Group type: COMPARATOR
Intervention: Sucrose (S)
Number of subjects: 102
Study 1066333 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol (X) in chewing gum
Number of subjects: 102
Study 1066333 — intervention group
Group type: COMPARATOR
Intervention: Sucrose (S) in chewing gum
Number of subjects: 102
Study 29506422 — intervention group
Group type: EXPERIMENTAL
Intervention: DEFB1 c.*87-A allele
Number of subjects: 101
Study 29506422 — intervention group
Group type: EXPERIMENTAL
Intervention: GCGA haplotype
Number of subjects: 101
Study 29506422 — intervention group
Group type: EXPERIMENTAL
Intervention: ACGG haplotype
Number of subjects: 101
Study 28928186 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTNK-tPA (16 mg intravenous bolus)
Number of subjects: 6200
Study 28928186 — intervention group
Group type: COMPARATOR
Intervention: Alteplase (rt-PA) (8 mg intravenous bolus followed by 42 mg infusion over 90 mins)
Number of subjects: 6200
Study 26341762 — intervention group
Group type: EXPERIMENTAL
Intervention: mini-laparoscopic donor nephrectomy (mLDN)
Number of subjects: 100
Study 26341762 — intervention group
Group type: COMPARATOR
Intervention: standard laparoscopic donor nephrectomy (sLDN)
Number of subjects: 100
Study 26341762 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (mLDN and sLDN)
Number of subjects: 100
Study 23555624 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-delivered Cognitive Behaviour Therapy (iCBT)
Number of subjects: 562
Study 23555624 — intervention group
Group type: COMPARATOR
Intervention: internet-delivered attention control health information package (HealthWatch)
Number of subjects: 562
Study 21802850 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage Therapy (MT)
Number of subjects: 72
Study 21802850 — intervention group
Group type: COMPARATOR
Intervention: Social attention control condition
Number of subjects: 72
Study 19367435 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% glyceryl trinitrate ointment and anal cryothermal dilators
Number of subjects: 60
Study 19367435 — intervention group
Group type: COMPARATOR
Intervention: 0.4% glyceryl trinitrate ointment alone
Number of subjects: 60
Study 16957424 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan-HCTZ (80/25 mg)
Number of subjects: 1066
Study 16957424 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan-HCTZ (160/25 mg)
Number of subjects: 1066
Study 16957424 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1066
Study 15042133 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitional food process (TFP) scale
Number of subjects: 6747
Study 15042133 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating ability index (EAI) calculated as (number of accepted foods/total number of foods) x 100
Number of subjects: 6747
Study 15042133 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast feeding, bottle feeding with chewing-type nipples, and family table food preparation
Number of subjects: 6747
Study 15042133 — intervention group
Group type: EXPERIMENTAL
Intervention: Information from books or magazines
Number of subjects: 6747
Study 11140546 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate 3.75 mg
Number of subjects: 100
Study 11140546 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate 7.5 mg
Number of subjects: 100
Study 11140546 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study 9074532 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc‐tetrofosmin
Number of subjects: 24
Study 9074532 — intervention group
Group type: COMPARATOR
Intervention: 99mTc‐sestamibi
Number of subjects: 24
Study 8362998 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention combining refusal skills training, contingency management, and telephone boosters
Number of subjects: 2668
Study 8362998 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2668
Study 8362998 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention vs Control
Number of subjects: 2668
Study 31583611 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone 20 mg once daily
Number of subjects: 0
Study 31583611 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone 10 mg once daily
Number of subjects: 0
Study 31583611 — intervention group
Group type: COMPARATOR
Intervention: Control not specified
Number of subjects: 0
Study 29166779 — intervention group
Group type: EXPERIMENTAL
Intervention: PA intervention (free PA classes, 6 times per week)
Number of subjects: 319
Study 29166779 — intervention group
Group type: COMPARATOR
Intervention: Attention control (cancer prevention workshops)
Number of subjects: 319